$28.07
0.00% today
NYSE, Nov 27, 01:00 am CET
ISIN
US5004723038
Symbol
PHG

Royal Philips NV Sponsored ADR Stock price

$28.07
-0.82 2.84% 1M
+5.52 24.48% 6M
+2.75 10.86% YTD
+1.16 4.31% 1Y
+14.72 110.30% 3Y
-18.91 40.25% 5Y
+3.69 15.15% 10Y
+2.82 11.17% 20Y
NYSE, Closing price Wed, Nov 26 2025
+0.22 0.79%

Key metrics

Basic
Market capitalization
$26.5b
Enterprise Value
$34.1b
Net debt
$7.7b
Cash
$2.1b
Shares outstanding
951.0m
Valuation (TTM | estimate)
P/E
140.4 | 17.4
P/S
1.3 | 1.3
EV/Sales
1.7 | 1.6
EV/FCF
67.8
P/B
2.2
Dividends
DPS
$0.97
Yield 1Y | 5Y
3.5% | 1.8%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
-111.2% | -28.5%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$20.7b | $21.0b
EBITDA
$3.5b | $3.4b
EBIT
$1.3b | $2.2b
Net Income
$187.8m | $1.5b
Free Cash Flow
$503.2m
Growth (TTM | estimate)
Revenue
-1.5% | 0.7%
EBITDA
204.2% | 23.5%
EBIT
476.2% | 98.4%
Net Income
138.5% | 288.1%
Free Cash Flow
-61.8%
Margin (TTM | estimate)
Gross
43.9%
EBITDA
16.9% | 16.0%
EBIT
6.1%
Net
0.9% | 7.3%
Free Cash Flow
2.4%
Financial Health
Equity Ratio
41.4%
Return on Equity
-5.9%
ROCE
5.7%
ROIC
1.1%
Debt/Equity
0.8
More
EPS
$0.2
FCF per Share
$0.5
Short interest
0.1%
Employees
67k
Rev per Employee
$310.0k
Show more

Is Royal Philips NV Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

15x Buy
56%
12x Hold
44%

Analyst Opinions

27 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy
56%
Hold
44%

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
20,704 20,704
2% 2%
100%
- Direct Costs 11,626 11,626
5% 5%
56%
9,078 9,078
4% 4%
44%
- Selling and Administrative Expenses 5,842 5,842
2% 2%
28%
- Research and Development Expense 2,045 2,045
2% 2%
10%
3,506 3,506
204% 204%
17%
- Depreciation and Amortization 2,241 2,241
51% 51%
11%
EBIT (Operating Income) EBIT 1,265 1,265
476% 476%
6%
Net Profit 188 188
138% 138%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Royal Philips NV Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Royal Philips NV Sponsored ADR Stock News

Neutral
GlobeNewsWire
3 days ago
November 24, 2025 New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, web diagnostic viewer [...
Neutral
GlobeNewsWire
8 days ago
November 19, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with Cortechs.ai, a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai's advanced AI-enabled neuroimaging analytics directly into Philips' MR systems [1], empowering clinicians with fast...
Neutral
GlobeNewsWire
10 days ago
November 17, 2025 Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence** Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one of int...
More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Roy Jakobs
Employees 66,678
Founded 1891
Website www.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today